The Medical Device Authority (MDA) of Malaysia and the Thai Food and Drug Administration (FDA) have initiated a three-month pilot programme to accelerate cross-border medical device registration.

• Streamlined Process: The pilot allows both regulators to rely on each other’s technical assessments for Class B, C, and D medical devices to reduce duplicate reviews.
• Timeline: The programme is scheduled to run from 1 February 2026 to 30 April 2026, targeting faster market entry for innovative technologies.
• Efficiency: In Malaysia, Thai-approved devices may see review times halved to 30 working days, while Thailand will waive certain expert fees for MDA-registered products.

This summary is based on a report by Andaman Medical.